Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Breast Cancer Research and Treatment
Erschienen in: Breast Cancer Research and Treatment 1/2009

01.03.2009 | Review

Breast-feeding after breast cancer: if you wish, madam

verfasst von: Hatem A. Azim Jr., Giulia Bellettini, Shari Gelber, Fedro A. Peccatori

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is the most common malignant tumor-affecting women during the child bearing period. With the rising trend in delaying pregnancy later in life, the issue of subsequent pregnancy and lactation following breast cancer diagnosis has been more frequently encountered. In this context, data is scarce particularly those addressing the issue of lactation. In this review, we discussed different endocrinal, clinical and biological aspects dealing with breast-feeding after breast cancer in an attempt to determine how safe and feasible this approach is.
Literatur
1.
Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17:588–590PubMedCrossRef
2.
Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A, Edwards BK (2006) Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107:1711–1742PubMedCrossRef
3.
Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, AlMalik O, Alshabanah M, Ezzat A, Al-Tweigeri T (2007) Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer 7:222PubMedCrossRef
4.
Adami HO, Malker B, Holmberg L, Persson I, Stone B (1986) The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315:559–563PubMedCrossRef
5.
Levi F, Lucchini F, Negri E, La Vecchia C (2007) Continuing declines in cancer mortality in the European Union. Ann Oncol 18:593–595PubMedCrossRef
6.
Berkowitz GS, Skovron ML, Lapinski RH, Berkowitz RL (1990) Delayed child-bearing and the outcome of pregnancy. N Engl J Med 322:639–664CrossRef
7.
Peccatori F, Cinieri S, Orlando L, Bellettini G (2008) Subsequent pregnancy after breast cancer. Recent Results Cancer Res 178:57–67PubMedCrossRef
8.
Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98:1131–1140PubMedCrossRef
9.
Sankila R, Heinavaara S, Hakulinen (1994) Survival of breast cancer patients after subsequent term pregnancy: “Healthy mother effect”. Am J Obstet Gynecol 170:818–823PubMed
10.
Janerich DT (2001) The fetal antigen hypothesis: cancers and beyond. Med Hypotheses 56:101–103PubMedCrossRef
11.
Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S (1999) Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96:2520–2525PubMedCrossRef
12.
Neville MC, Morton JA, Umemora S (2001) Lactogenesis: the transition between pregnancy and lactation. Pediatr Clin North Am 48:35–52PubMedCrossRef
13.
Traurig HH (1967) Cell proliferation in the mammary gland during late pregnancy and lactation. Anat Rec 157:489–504CrossRef
14.
Furth PA (1999) Mammary gland involution and apoptosis of mammary epithelial cells. J Mammary Gland Biol Neoplasia 4:123–127PubMedCrossRef
15.
Zembo CT (2002) Breastfeeding. Obset Gynecol Clin North Am 29:51–76CrossRef
16.
Agostoni C, Trojan S, Bellu R, Riva E, Bruzzese MG, Giovannini M (1997) Development quotient at 24 months and fatty acid composition of diet in early infancy: a follow-up study. Arch Dis Child 76:421–424PubMedCrossRef
17.
Anderson JW, Johnstone BM, Remley DT (1999) Breast-feeding and cognitive development. A meta-analysis. Am J Clin Nutr 70:525–535PubMed
18.
Kjos SL, Henry O, Lee RM, Buchanan TA, Michel DR (1993) The effect of lactation on glucose and lipid metabolism in women with recent gestational diabetes. Obstet Gynecol 2:451–455
19.
Lipworth L, Bailey LR, Trichopoulos D (2000) History of breast-feeding in relation to breast cancer risk: a review of the epidemiological literature. J Natl Cancer Inst 92:302–312PubMedCrossRef
20.
Collaborative Group on Hormonal factors, breastfeeding (2000) Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 260:187–195
21.
Freund C, Mirabel L, Annane K, Mathelin C (2005) Breastfeeding and breast cancer. Gynecol Obstet Fertil 33:739–744PubMedCrossRef
22.
Jernstrom H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA (2004) Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 96:1094–1098PubMed
23.
Harris JR, Lippman ME, Veronesi U, Willett W (1992) Breast cancer (2). N Engl J Med 327:390–398PubMedCrossRef
24.
Moysich KB, Ambrosone CB, Vena JE, Shields PG, Mendola P, Kostyniak P, Greizerstein H, Graham S, Marshall JR, Schisterman EF, Freudenheim JL (1998) Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:181–188PubMed
25.
Ing R, Petrakis NL, Ho JH (1977) Unilateral breast-feeding and breast cancer. Lancet 2:124–127PubMedCrossRef
26.
McNeilly AS, Tay CC, Glasier A (1994) Physiological mechanisms underlying lactational amenorrhea. Ann N Y Acad Sci 709:145–155PubMedCrossRef
27.
McNeilly AS (2001) Neuroendocrine changes and fertility in breast-feeding women. Prog Brain Res 133:207–214PubMedCrossRef
28.
Clavel-Chapelon F, E3N Group (2002) Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 13:831–838
29.
Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7:131–142PubMedCrossRef
30.
Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244–278PubMed
31.
Clevenger CV, Chang WP, Ngo W, Pasha TM, Montone KT, Tomaszewski JE (1995) Expression of prolactin and prolactin receptor in human breast carcinoma. Am J Pathol 146:695–705PubMed
32.
Ginsburg E, Vonderhaar BK (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 55:2591–2595PubMed
33.
Fenton SE, Sheffield LG (1994) Control of mammary epithelial cell DNA synthesis by epidermal growth factor, cholera toxin, and IGF-1: specific inhibitory effect of prolactin on EGF-stimulated cell growth. Exp Cell Res 210:102–106PubMedCrossRef
34.
Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292–1299PubMedCrossRef
35.
Williams RH (ed) (1981) Textbook of endocrinology. W.B. Saunders Co., Philadelphia, London
36.
Tworoger SS, Eliassen AH, Sluss P, Hankinson SE (2007) A prospective study of plasma prolactin concentration and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 25:1482–1488PubMedCrossRef
37.
Turkington RW, Underwood LE, Van Wyk JJ (1971) Elevated serum prolactin levels after pituitary-stalk section in man. N Engl J Med 285:707–710PubMedCrossRef
38.
Wang DY, Hampson S, Kwa HG, Moore JW, Bilbrook RD, Fentiman IS, Hayward JL, King RJ, Millis RR, Rubens RD (1986) Serum prolactin levels in women with breast cancer and their relationship to survival. Eur J Cancer Clin Oncol 22:487–492PubMedCrossRef
39.
Hennighausen L, Robinson GW, Wagner KU, Liu W (1997) Prolactin signaling in mammary gland development. J Biol Chem 272:7567–7569PubMedCrossRef
40.
Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H (2004) Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 22:2053–2060PubMedCrossRef
41.
Goodman G, Bercovich D (2008) Prolactin does not cause breast cancer and may prevent it or be therapeutic in some conditions. Med Hypotheses 70:244–251PubMedCrossRef
42.
Polyak K (2006) Pregnancy and breast cancer: the other side of the coin. Cancer Cell 9:151–153PubMedCrossRef
43.
Gelber S, Coates AS, Goldhirsch A, Castiglione-Gertsch M, Marini G, Lindtner J, Eselmann DZ, Gudgeon A, Harvey V, Gelber RD, International Breast Cancer Study Group (2001) Effect of pregnancy on overall survival after the diagnosis of early stage breast cancer. J Clin Oncol 19:1671–1675
44.
Higgins S, Haffty BG (1994) Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer 73:2175–2180PubMedCrossRef
45.
Tralins AH (1994) Lactation after conservative breast surgery combined with radiation therapy. Am J Clin Oncol 18:40–43CrossRef
46.
Moran MS, Colasanto JM, Haffty BG, Wilson LD, Lund MW, Higgins SA (2005) Effects of breast-conserving therapy on lactation after pregnancy. Cancer J 11:399–403PubMedCrossRef
47.
Schnit SJ, Goldwyn RM, Slavin SA (1993) Mammary ducts in the areola: implications for patients undergoing reconstructive surgery of the breast. Plast Reconstr Surg 92:1290–1293
48.
Riordan J, Gill-Hopple K, Angeron J (2005) Indicators of effective breastfeeding and estimates of breast milk intake. J Hum Lact 21:406–412PubMedCrossRef
49.
Walker M (2006) Breastfeeding management for the clinician: using the evidence. Jones and Bartlett Publishers, Boston, MA
50.
Blair A, Cadwell K, Turner-Maffei C, Brimdyr K (2003) The relationship between positioning, the breastfeeding dynamic, the latching process and pain in breastfeeding mothers with sore nipples. Breastfeeding Rev 11:5–10
51.
Auerbach KG (1990) Sequential and simultaneous breast pumping: a comparison. Int J Nurs Stud 27:257–265PubMedCrossRef
52.
Obenauer S, Dammert S (2007) Palpable masses in breast during lactation. Clin Imaging 31:1–5PubMedCrossRef
53.
Samuel J (1997) Breastfeeding and the empowerment of women. Can Nurse 93:47–48PubMed
54.
Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM, Breast Disease Committee, Executive Committee and Council, Society of Obstetricians and Gynaecologists of Canada (2002) Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 24:164–180
Metadaten
Titel
Breast-feeding after breast cancer: if you wish, madam
verfasst von
Hatem A. Azim Jr.
Giulia Bellettini
Shari Gelber
Fedro A. Peccatori
Publikationsdatum
01.03.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-9983-7

Weitere Artikel der Ausgabe 1/2009

Breast Cancer Research and Treatment 1/2009 Zur Ausgabe

Epidemiology

Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series

Preclinical Study

Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts

Epidemiology

Weight changes after adjuvant treatment in Korean women with early breast cancer

Preclinical Study

The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal

Epidemiology

Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors

Preclinical Study

The effect of thrombospondin-1 on breast cancer metastasis

Neu im Fachgebiet Onkologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise